NVR CLL (Tekturna HCT 150 mg-25 mg)

Generic Name: aliskiren/hydrochlorothiazide

Pill imprint NVR CLL has been identified as Tekturna HCT 150 mg-25 mg.

Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class miscellaneous antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Tekturna HCT 150 mg-25 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for NVR CLL

Tekturna HCT 150 mg-25 mg NVR CLL
Tekturna HCT
Generic Name:
aliskiren/hydrochlorothiazide
Imprint:
NVR
CLL
Strength:
150 mg-25 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Miscellaneous antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0522
Inactive Ingredients:
silicon dioxide
crospovidone
hypromelloses
ferric oxide red
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
wheat starch

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)